Table 2.

Clinical data of the patients with Burkholderia capecia keratitis

	Age/sex	Risk factor	Prior steroid use	Location, size	Hypopyon	Medical treatment	Surgery	Presenting VA	Final VA	Other isolates\
Matoba et al. [7]	59/m	HSV keratitis	+	C, M	-	Levofloxacin	-	CF	20/200	Enterococcus species, Staphylococcus aureus
Lin et al. [5]	16/f	Ortho-keratology lens	–	PC, S	–	Ciprofloxacin	–	20/40	20/20	Pseudomonas putida, Pseudomonas aeruginosa.
Ornek et al. [18]a	78/f	Cataract surgery	+	C, M	–	Ciprofloxacin +IVI Ceftazidime	–	NLP	NA
Chaurasia et al. [4]	NA	Unknown	+	NA, M	–	Ciprofloxacin	Tissue adhesive	LP	NA
	NA	Unknown	–	NA, S	+	Ciprofloxacin	–	NA	NA
	NA	Trauma	–	NA, L	+	Ciprofloxacin	TPK	LP	NA
	NA	TPK	+	NA, S	–	Ceftazidime	–	HM	NA
Reddy et al. [9]	27/m	LASIK	+	C, multiple infiltrates	+	Tobramycin and Gatifloxacin		CF	20/20

C  central, CF  counting fingers, f  female, HM  hand motion, IVI  intravitreal injection, L  large, LASIK  laser assisted in situ keratomileusis, LP  light perception, m  male, M  medium, NA  not available, NLP  no light perception, PC  paracentral, S  small, TPK  therapeutic penetrating keratoplasty

^a A case of keratitis and endophthalmitis